aldosterone has been researched along with Canine Diseases in 40 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "The effects of sacubitril/valsartan (S/V) on the renin-angiotensin-aldosterone system (RAAS) in dogs with cardiomegaly secondary to myxomatous mitral valve disease (MMVD) are currently unknown." | 9.27 | A prospective, randomized, double-blind, placebo-controlled pilot study of sacubitril/valsartan (Entresto) in dogs with cardiomegaly secondary to myxomatous mitral valve disease. ( Duran, SH; Jung, S; Newhard, DK; Winter, RL, 2018) |
| "The effects of sacubitril/valsartan (S/V) on the renin-angiotensin-aldosterone system (RAAS) in dogs with cardiomegaly secondary to myxomatous mitral valve disease (MMVD) are currently unknown." | 5.27 | A prospective, randomized, double-blind, placebo-controlled pilot study of sacubitril/valsartan (Entresto) in dogs with cardiomegaly secondary to myxomatous mitral valve disease. ( Duran, SH; Jung, S; Newhard, DK; Winter, RL, 2018) |
| "To determine what effects long-term phenobarbital administration to dogs with epilepsy would have on serum biochemical factors and adrenocortical function." | 3.69 | Effects of phenobarbital administration on results of serum biochemical analyses and adrenocortical function tests in epileptic dogs. ( Chauvet, AE; Feldman, EC; Kass, PH, 1995) |
| "Aldosterone breakthrough was not associated with proteinuria outcome." | 1.72 | Prevalence of aldosterone breakthrough in dogs receiving renin-angiotensin system inhibitors for proteinuric chronic kidney disease. ( Ames, MK; Atkins, CE; Bove, C; Grauer, GF; Langston, CE; Palerme, JS; Shropshire, S; Vaden, SL; Webb, T, 2022) |
| " The correct trilostane dosage in dogs with PDH was based on the resolution of clinical signs and the results of an adrenocorticotropic hormone (ACTH) stimulation test." | 1.36 | Effects of trilostane on the pituitary-adrenocortical and renin-aldosterone axis in dogs with pituitary-dependent hypercortisolism. ( Buijtels, JJCWM; Galac, S; Kooistra, HS; Mol, JA, 2010) |
| "Pimobendan has a dual mechanism of action: it increases myocardial contractility by increasing calcium sensitization to troponin C and it promotes vasodilation by inhibiting PDEIII." | 1.34 | Effects of pimobendan for mitral valve regurgitation in dogs. ( Hara, A; Kanno, N; Kano, R; Kawasaki, M; Kuse, H; Sasaki, Y, 2007) |
| "Treatment with mitotane was instituted and successful for a period of 4-months until the dog was euthanatized for neurologic problems that were most likely unrelated to endocrine disease." | 1.33 | Corticosterone- and aldosterone-secreting adrenocortical tumor in a dog. ( Behrend, EN; Kemppainen, RJ; Refsal, KR; Weigand, CM; Whitley, EM; Young, DW, 2005) |
| "To evaluate the effect of dilated cardiomyopathy (DCM) on activity of the renin-angiotensin-aldosterone system (RAAS), the N-terminal fragment of proatrial natriuretic peptide (NT-proANP), and thyroid hormone concentrations in dogs." | 1.31 | Effects of dilated cardiomyopathy on the renin-angiotensin-aldosterone system, atrial natriuretic peptide activity, and thyroid hormone concentrations in dogs. ( Häggström, J; Hansson, K; Tidholm, A, 2001) |
| "Furosemide was added after the 3-week examination, and at 6 months, dogs had received furosemide for at least 4 months." | 1.29 | Effects of long-term treatment with enalapril or hydralazine on the renin-angiotensin-aldosterone system and fluid balance in dogs with naturally acquired mitral valve regurgitation. ( Häggström, J; Hansson, K; Karlberg, BE; Kvart, C; Madej, A; Olsson, K, 1996) |
| "Idiopathic hyperaldosteronism was diagnosed in an 8-year-old castrated male Yorkshire Terrier, based on increased concentration of plasma aldosterone, hypertension, hypernatremia, decreased natriuresis, hypokalemia, and hyperkaluria." | 1.27 | Idiopathic hyperaldosteronism in a dog. ( Anson, LW; Breitschwerdt, EB; Cook, CS; Fulghum, RE; Greenfield, CL; Meuten, DJ, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (17.50) | 18.7374 |
| 1990's | 8 (20.00) | 18.2507 |
| 2000's | 12 (30.00) | 29.6817 |
| 2010's | 8 (20.00) | 24.3611 |
| 2020's | 5 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, CJ | 1 |
| Mandour, AS | 1 |
| Yoshida, T | 1 |
| Watari, T | 2 |
| Tanaka, R | 1 |
| Matsuura, K | 1 |
| Grandt, LM | 1 |
| Schweighauser, A | 1 |
| Kovacevic, A | 1 |
| Francey, T | 1 |
| Ames, MK | 3 |
| Vaden, SL | 1 |
| Atkins, CE | 4 |
| Palerme, JS | 1 |
| Langston, CE | 1 |
| Grauer, GF | 1 |
| Shropshire, S | 1 |
| Bove, C | 1 |
| Webb, T | 1 |
| Sakamoto, Y | 1 |
| Sakai, M | 1 |
| Sato, K | 1 |
| Galizzi, A | 1 |
| Bagardi, M | 1 |
| Stranieri, A | 1 |
| Zanaboni, AM | 1 |
| Malchiodi, D | 1 |
| Borromeo, V | 1 |
| Brambilla, PG | 1 |
| Locatelli, C | 1 |
| Eriksson, A | 1 |
| Hess, AM | 1 |
| Newhard, DK | 1 |
| Jung, S | 1 |
| Winter, RL | 1 |
| Duran, SH | 1 |
| Yata, M | 1 |
| Kooistra, HS | 5 |
| Beijerink, NJ | 1 |
| Pitt, B | 1 |
| Mishina, M | 1 |
| Watanabe, T | 1 |
| Galac, S | 1 |
| Buijtels, JJCWM | 1 |
| Mol, JA | 3 |
| Klein, SC | 1 |
| Peterson, ME | 1 |
| McGraw, AL | 1 |
| Whitley, EM | 2 |
| Lee, HP | 1 |
| Boothe, DM | 1 |
| Behrend, EN | 2 |
| Hezzell, MJ | 1 |
| Boswood, A | 1 |
| Chang, YM | 1 |
| Moonarmart, W | 1 |
| Elliott, J | 1 |
| Goy-Thollot, I | 1 |
| Péchereau, D | 1 |
| Kéroack, S | 1 |
| Dezempte, JC | 1 |
| Bonnet, JM | 1 |
| BOJS, GE | 1 |
| CONN, HL | 2 |
| Javadi, S | 1 |
| Boer, P | 3 |
| Boer, WH | 2 |
| Rijnberk, A | 3 |
| Wenger, M | 2 |
| Sieber-Ruckstuhl, NS | 2 |
| Müller, C | 1 |
| Reusch, CE | 2 |
| Weigand, CM | 1 |
| Refsal, KR | 1 |
| Young, DW | 1 |
| Kemppainen, RJ | 1 |
| Boretti, FS | 1 |
| Maser-Gluth, C | 1 |
| Kanno, N | 1 |
| Kuse, H | 1 |
| Kawasaki, M | 1 |
| Hara, A | 1 |
| Kano, R | 1 |
| Sasaki, Y | 1 |
| Gardner, SY | 1 |
| Rausch, WP | 1 |
| DeFrancesco, TC | 1 |
| Chandler, DW | 1 |
| Keene, BW | 1 |
| Machida, T | 1 |
| Uchida, E | 1 |
| Matsuda, K | 1 |
| Hirayama, K | 1 |
| Yoshii, K | 1 |
| Takiguchi, M | 1 |
| Taniyama, H | 1 |
| Willard, MD | 2 |
| Schall, WD | 1 |
| McCaw, DE | 1 |
| Nachreiner, RF | 2 |
| Chauvet, AE | 1 |
| Feldman, EC | 1 |
| Kass, PH | 1 |
| Kittleson, MD | 2 |
| Johnson, LE | 1 |
| Pion, PD | 1 |
| Mekhamer, YE | 1 |
| Koch, J | 1 |
| Pedersen, HD | 3 |
| Jensen, AL | 1 |
| Flagstad, A | 1 |
| Poulsen, K | 1 |
| Häggström, J | 3 |
| Hansson, K | 3 |
| Karlberg, BE | 2 |
| Kvart, C | 2 |
| Madej, A | 1 |
| Olsson, K | 2 |
| Vuolteenaho, O | 1 |
| Dunn, KJ | 1 |
| Herrtage, ME | 1 |
| Olsen, LH | 1 |
| Mow, T | 1 |
| Christensen, NJ | 1 |
| Tidholm, A | 1 |
| van Vonderen, IK | 1 |
| Voorhout, G | 1 |
| van Sluijs, FJ | 1 |
| IJzer, J | 1 |
| van den Ingh, TS | 1 |
| Schaafsma, IA | 1 |
| van Emst, MG | 1 |
| Verkleij, CB | 1 |
| Peeters, ME | 1 |
| Everts, ME | 1 |
| Knowlen, GG | 1 |
| Eyster, GE | 1 |
| Detweiler, DK | 2 |
| Knight, DH | 1 |
| Refsal, K | 1 |
| Thacker, E | 1 |
| Breitschwerdt, EB | 1 |
| Meuten, DJ | 1 |
| Greenfield, CL | 1 |
| Anson, LW | 1 |
| Cook, CS | 1 |
| Fulghum, RE | 1 |
| McGiff, J | 1 |
| Luchi, RJ | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Safety and Feasibility Study of Water-only Fasting and Refeeding for Treatment of Stage 1 and 2 Hypertensive Patients[NCT04515095] | 30 participants (Actual) | Interventional | 2020-08-16 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 reviews available for aldosterone and Canine Diseases
| Article | Year |
|---|---|
The renin-angiotensin-aldosterone system and its suppression.
Topics: Aldosterone; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibit | 2019 |
Canine hypoadrenocorticism: part I.
Topics: Addison Disease; Age Factors; Aldosterone; Animals; Dog Diseases; Dogs; Female; Hydrocortisone; Male | 2010 |
Canine hypoadrenocorticism: report of 37 cases and review of 39 previously reported cases.
Topics: Addison Disease; Aldosterone; Animals; Blood Glucose; Dog Diseases; Dogs; Female; Hypercalcemia; Hyp | 1982 |
Congestive heart failure in dogs: therapeutic concepts.
Topics: Aldosterone; Animals; Blood Volume; Cardiac Output; Diet, Sodium-Restricted; Digitalis Glycosides; D | 1977 |
2 trials available for aldosterone and Canine Diseases
| Article | Year |
|---|---|
A prospective, randomized, double-blind, placebo-controlled pilot study of sacubitril/valsartan (Entresto) in dogs with cardiomegaly secondary to myxomatous mitral valve disease.
Topics: Aldosterone; Aminobutyrates; Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Blood Pr | 2018 |
Development of hypertension and effects of benazepril hydrochloride in a canine remnant kidney model of chronic renal failure.
Topics: Aldosterone; Angiotensin I; Angiotensin II; Animals; Antihypertensive Agents; Benzazepines; Blood Pr | 2008 |
34 other studies available for aldosterone and Canine Diseases
| Article | Year |
|---|---|
Changes in renin-angiotensin-aldosterone system during cardiac remodeling after mitral valvuloplasty in dogs.
Topics: Aldosterone; Animals; Cohort Studies; Dog Diseases; Dogs; Humans; Mitral Valve; Renin-Angiotensin Sy | 2022 |
The circulating renin-angiotensin-aldosterone system is down-regulated in dogs with glomerular diseases compared to other chronic kidney diseases with low-grade proteinuria.
Topics: Aldosterone; Animals; Atrial Natriuretic Factor; Azotemia; Blood Urea Nitrogen; Dog Diseases; Dogs; | 2022 |
Prevalence of aldosterone breakthrough in dogs receiving renin-angiotensin system inhibitors for proteinuric chronic kidney disease.
Topics: Aldosterone; Animals; Antihypertensive Agents; Creatinine; Dog Diseases; Dogs; Prevalence; Prospecti | 2022 |
Plasma renin activity and aldosterone concentration in dogs with acquired portosystemic collaterals.
Topics: Aldosterone; Animals; Case-Control Studies; Collateral Circulation; Dog Diseases; Dogs; Female; Hepa | 2020 |
Factors affecting the urinary aldosterone-to-creatinine ratio in healthy dogs and dogs with naturally occurring myxomatous mitral valve disease.
Topics: Aldosterone; Animals; Creatinine; Dog Diseases; Dogs; Female; Furosemide; Heart Valve Diseases; Male | 2021 |
Aldosterone breakthrough in dogs with naturally occurring myxomatous mitral valve disease.
Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Animals; Creatinine; Dog Diseases; Dogs; Fema | 2017 |
Cardiorenal and endocrine effects of synthetic canine BNP1-32 in dogs with compensated congestive heart failure caused by myxomatous mitral valve disease.
Topics: Aldosterone; Animals; Cross-Over Studies; Dog Diseases; Dogs; Furosemide; Heart Failure; Heart Valve | 2019 |
Effects of trilostane on the pituitary-adrenocortical and renin-aldosterone axis in dogs with pituitary-dependent hypercortisolism.
Topics: Adrenocorticotropic Hormone; Aldosterone; Animals; Dihydrotestosterone; Dog Diseases; Dogs; Dose-Res | 2010 |
Determination of the concentrations of trilostane and ketotrilostane that inhibit ex vivo canine adrenal gland synthesis of cortisol, corticosterone, and aldosterone.
Topics: Adrenal Glands; Adrenocortical Hyperfunction; Aldosterone; Animals; Corticosterone; Dihydrotestoster | 2011 |
Associations among serum N-terminal procollagen type III concentration, urinary aldosterone-to-creatinine ratio, and ventricular remodeling in dogs with myxomatous mitral valve disease.
Topics: Aldosterone; Animals; Creatinine; Dog Diseases; Dogs; Female; Male; Mitral Valve Prolapse; Peptide F | 2012 |
Investigation of the role of aldosterone in hypertension associated with spontaneous pituitary-dependent hyperadrenocorticism in dogs.
Topics: Adrenocortical Hyperfunction; Adrenocorticotropic Hormone; Aldosterone; Animals; Antineoplastic Agen | 2002 |
DISTRIBUTION OF BODY SODIUM, POTASSIUM, AND WATER AND THE EXCRETION OF ALDOSTERONE IN DOGS WITH SPONTANEOUS HEART FAILURE.
Topics: Aldosterone; Animals; Ascites; Dog Diseases; Dogs; Edema; Heart Failure; Humans; Mitral Valve Insuff | 1965 |
Plasma aldosterone concentrations and plasma renin activity in healthy dogs and dogs with hyperadrenocorticism.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Hyperfunction; Adrenocorticotropic Hormone; Aldosterone; An | 2003 |
Effect of trilostane on serum concentrations of aldosterone, cortisol, and potassium in dogs with pituitary-dependent hyperadrenocorticism.
Topics: Adrenocortical Hyperfunction; Adrenocorticotropic Hormone; Aldosterone; Analysis of Variance; Animal | 2004 |
Corticosterone- and aldosterone-secreting adrenocortical tumor in a dog.
Topics: Adrenal Cortex Neoplasms; Aldosterone; Animals; Antineoplastic Agents, Hormonal; Corticosterone; Dog | 2005 |
Cortisol, aldosterone, cortisol precursor, androgen and endogenous ACTH concentrations in dogs with pituitary-dependant hyperadrenocorticism treated with trilostane.
Topics: 17-alpha-Hydroxypregnenolone; 3-Hydroxysteroid Dehydrogenases; Adrenocortical Hyperfunction; Adrenoc | 2006 |
Effects of pimobendan for mitral valve regurgitation in dogs.
Topics: Aldosterone; Animals; Atrial Natriuretic Factor; Blood Pressure; Cardiotonic Agents; Catecholamines; | 2007 |
Estimation of 24-h aldosterone secretion in the dog using the urine aldosterone:creatinine ratio.
Topics: Aldosterone; Animals; Creatinine; Dog Diseases; Dogs; Female; Male; Radioimmunoassay; Renin-Angioten | 2007 |
Aldosterone-, corticosterone- and cortisol-secreting adrenocortical carcinoma in a dog: case report.
Topics: Adrenal Glands; Adrenocortical Carcinoma; Aldosterone; Animals; Corticosterone; Dihydrotestosterone; | 2008 |
Effects of phenobarbital administration on results of serum biochemical analyses and adrenocortical function tests in epileptic dogs.
Topics: Adrenal Cortex; Adrenal Cortex Function Tests; Adrenocorticotropic Hormone; Alanine Transaminase; Al | 1995 |
The acute haemodynamic effects of captopril in dogs with heart failure.
Topics: Administration, Oral; Aldosterone; Animals; Blood Pressure; Captopril; Cardiac Output; Cardiac Outpu | 1993 |
Activation of the renin-angiotensin system in dogs with asymptomatic and symptomatic dilated cardiomyopathy.
Topics: Aldosterone; Animals; Cardiomyopathy, Dilated; Dog Diseases; Dogs; Female; Heart Failure; Male; Refe | 1995 |
Effects of mild mitral valve insufficiency, sodium intake, and place of blood sampling on the renin-angiotensin system in dogs.
Topics: Aldosterone; Animals; Controlled Clinical Trials as Topic; Diet, Sodium-Restricted; Dog Diseases; Do | 1996 |
Effects of long-term treatment with enalapril or hydralazine on the renin-angiotensin-aldosterone system and fluid balance in dogs with naturally acquired mitral valve regurgitation.
Topics: Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Body Weight; Dog Dis | 1996 |
Effects of naturally acquired decompensated mitral valve regurgitation on the renin-angiotensin-aldosterone system and atrial natriuretic peptide concentration in dogs.
Topics: Aldosterone; Angiotensin II; Animals; Atrial Natriuretic Factor; Blood Pressure; Creatinine; Dog Dis | 1997 |
Hypocortisolaemia in a Labrador retriever.
Topics: Addison Disease; Adrenocorticotropic Hormone; Aldosterone; Animals; Carbon Dioxide; Dog Diseases; Do | 1998 |
Neuroendocrine changes in Dachshunds with mitral valve prolapse examined under different study conditions.
Topics: Aldosterone; Animals; Dog Diseases; Dogs; Eating; Epinephrine; Fasting; Humans; Hydrocortisone; Magn | 1999 |
Effects of dilated cardiomyopathy on the renin-angiotensin-aldosterone system, atrial natriuretic peptide activity, and thyroid hormone concentrations in dogs.
Topics: Aldosterone; Animals; Atrial Natriuretic Factor; Cardiomyopathy, Dilated; Creatinine; Dog Diseases; | 2001 |
Aldosteronoma in a dog with polyuria as the leading symptom.
Topics: Adrenalectomy; Aldosterone; Animals; Dog Diseases; Dogs; Hyperaldosteronism; Male; Osmolar Concentra | 2001 |
Exercise-induced hyperkalemia in hypothyroid dogs.
Topics: Aldosterone; Animals; Creatine Kinase; Dog Diseases; Dogs; Female; Homeostasis; Hyperkalemia; Hypoth | 2002 |
Comparison of plasma aldosterone concentration among clinical status groups of dogs with chronic heart failure.
Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Captopril; | 1983 |
Evaluation of plasma aldosterone concentrations before and after ACTH administration in clinically normal dogs and in dogs with various diseases.
Topics: Adrenal Insufficiency; Adrenocorticotropic Hormone; Aldosterone; Animals; Dog Diseases; Dogs; Female | 1987 |
Idiopathic hyperaldosteronism in a dog.
Topics: Adrenal Glands; Adrenocorticotropic Hormone; Aldosterone; Animals; Dog Diseases; Dogs; Humans; Hydro | 1985 |
Why we have gone to the dogs.
Topics: Aldosterone; Animals; Cardiac Output; Dog Diseases; Dogs; Exercise Test; Guanethidine; Heart; Heart | 1966 |